Blog

Fall Rosacea Review

Posted: 11/29/2007

The Fall 2007 Rosacea Review is now online at rosacea.org. This issue includes an article on potential new treatment advances presented at the NRS's research workshop during the Society for Investigative Dermatology annual meeting, publication of a breakthrough study, survey results on cosmetics and rosacea, and news about a new scoring system for ocular rosacea.



Danger Signs of Red-Faced Disorder Strike Millions of Adults at Any Age

Posted: 4/2/2007

The angst and embarrassment of adolescence often come roaring back in adulthood with the red-faced symptoms of rosacea, a widespread but poorly understood facial disorder now estimated to affect 14 million Americans.



NRS Marks 15th Anniversary

Posted: 3/20/2007

As the National Rosacea Society (NRS) marks its 15th anniversary in 2007, we are pleased to report the immense progress that has been made in achieving our mission of improving the lives of people with rosacea through awareness, education and support of medical research on this widespread but poorly understood disorder.



Winter Rosacea Review

Posted: 2/21/2007

The Winter 2007 issue of Rosacea Review is now available on rosacea.org.



Awareness Month in April

Posted: 2/7/2007

Rosacea Awareness Month to Highlight Wide Prevalence of Chronic Condition

 More than 14 million Americans are estimated to suffer from rosacea, yet most of them fail to recognize it. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to alert the public to the warning signs of this embarrassing and potentially life-disruptive facial disorder, and to emphasize the importance of seeking medical help.



Dark Side of ATP

Posted: 1/5/2007

New Study Uncovers the Dark Side of ATP

Researchers have found that one of the most common and hard-working substances in the body may have a Jekyll and Hyde quality in rosacea patients, assuming a darker role when activated by flare-up triggers.



New Drug Introduced

Posted: 7/25/2006

The following announcement was issued by CollaGenex Pharmaceuticals:

FIRST ORAL DRUG FOR ROSACEA
COLLAGENEX PHARMACEUTICALS
INTRODUCES ORACEA™

(doxycycline, USP) capsules 40 mg*
* 30 mg immediate release and 10 mg delayed release beads



Dry Eye Awareness

Posted: 7/7/2006

The following announcement was issued by the National Women's Health Resource Center:

Do You Live in a Dry Eye Hot Spot?



Trail of Tears May Lead Scientists To First Diagnostic Test for Rosacea

Posted: 6/14/2006

BARRINGTON, Illinois (June 14, 2006) -- A trail of tears may lead to the first diagnostic test for ocular rosacea, a common and potentially serious condition that may result in reduction of vision if left untreated. In a study of human tears funded by the National Rosacea Society (NRS) and published in Rosacea Review, medical scientists have discovered new clues to identify the eye effects of rosacea, a red-faced, acne-like disorder now estimated to affect 14 million Americans.



Summer Rosacea Review

Posted: 6/6/2006

The summer 2006 issue of Rosacea Review is now available on rosacea.org.



Survey Finds Facial Disorder Hurts More Than Appearance

Posted: 2/20/2006

While the often-devastating impact of rosacea on facial appearance is well recognized, a new survey shows that physical discomfort is also experienced by the majority of people with this red-faced, acne-like disorder now estimated to affect more than 14 million Americans.



New Research Grants Awarded to Further Knowledge of Rosacea

Posted: 1/11/2006

The National Rosacea Society (NRS) announced that five new studies have been awarded funding as part of its research grants program to advance scientific knowledge of the potential causes and other key aspects of this chronic and potentially devastating disorder that affects an estimated 14 million Americans.